Skip to content
Get BIO’s view on everything from health care to biofuels and the bioeconomy. The below articles include BIO statements, opinion, and calls to action, as well as articles and op-eds written by BIO leadership.
Is the accelerated approval pathway helping patients achieve better health outcomes or imposing on society medicines that don’t work? In BIO’s view, the pathway […]
Setting the record straight on accelerated approval Read More »
France’s government is putting €54 billion toward the growth of priority industries, including the biotech sector, learned a high-level delegation to Paris organized by
BIO’s Paris delegation strengthens Franco-American biotech ties Read More »
Sen. Bernie Sanders (I-Vt.), Chair of the Senate Health, Education, Labor, and Pensions Committee, announced that he is launching an investigation into the pricing
Company presentations at the BIO International Convention put innovators on stage before a small but important audience, helping them engage in the networking and
Company presentations at BIO 2024 inspire partnering Read More »
On April 18, 2024, the Biotechnology Innovation Organization (BIO) held the inaugural Agriculture & Environment Summit in Washington, D.C., bringing together government and industry
John F. Crowley: ‘Biotechnology is another word for hope’ Read More »
On April 10, Life Sciences PA awarded Biotechnology Innovation Organization (BIO) President & CEO John F. Crowley the Hubert J.P. Schoemaker Leadership Award. The
Life Sciences PA recognizes John F. Crowley for biotech leadership Read More »
April began with the 2024 World Vaccine Congress in Washington, D.C., where Biotechnology Innovation Organization (BIO) leaders and members highlighted developments in life-saving vaccine
World Vaccine Congress 2024 highlights innovation, messaging strategies Read More »
A year ago, the sentiment for the industry was extremely low. In 2023, the biotech stock indices were sliding to potential new lows, levels
5 reasons for investor optimism at BIO-Europe Spring 2024 Read More »
Editor’s Note: On Wednesday, May 1, 2024, the California Supreme Court said it will consider Gilead’s request for summary dismissal, agreeing with BIO’s March
BIO opposes lawsuit that would penalize drugmaker for innovating too slowly Read More »
The Inflation Reduction Act (IRA) is expected to have broad negative impacts on patients, most notably through less access to future cures and treatments.
Heart disease patients and the IRA’s misguided incentives Read More »
